Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Cancer Treatment Reviews
|
July 6, 2020
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Florian Slimano, Amandine Baudouin, Jérémie Zerbit, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2018
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients
Olivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2016
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Michael Philippe, Florence Ranchon, Lila Gilis, et al.
BMC Pharmacology & Toxicology
|
January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factors
Marie Parel, Florence Ranchon, Audrey Nosbaum, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 8, 2021
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program
Florent Charra, Michael Philippe, Chloé Herledan, et al.
Plos One
|
December 4, 2020
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects
Juliette Périchou, Florence Ranchon, Chloé Herledan, et al.
Annales Pharmaceutiques Francaises
|
July 12, 2025
Oncology pharmacy practice: Key insights, challenges, and perspectives - A position paper from the French Society for Oncology Pharmacy (SFPO)
Florence Ranchon, Florian Slimano, Isabelle Borget, et al.
Annals of Hematology
|
October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
Emilie Fargier, Florence Ranchon, Laure Huot, et al.
Hematological Oncology
|
October 23, 2025
The French Experience of Pharmacists and CAR T-Cells: A Study of the French Society of Oncology Pharmacy (SFPO)
Vérane Schwiertz, Romain de Jorna, Adeline Quintard, et al.
Cancers
|
February 15, 2022
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
Bastien Collomb, Amélie Dubromel, Anne Gaëlle Caffin, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Cancer Treatment Reviews
|
July 6, 2020
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Florian Slimano, Amandine Baudouin, Jérémie Zerbit, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2018
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients
Olivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2016
Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Michael Philippe, Florence Ranchon, Lila Gilis, et al.
BMC Pharmacology & Toxicology
|
January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factors
Marie Parel, Florence Ranchon, Audrey Nosbaum, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 8, 2021
Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program
Florent Charra, Michael Philippe, Chloé Herledan, et al.
Plos One
|
December 4, 2020
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects
Juliette Périchou, Florence Ranchon, Chloé Herledan, et al.
Annales Pharmaceutiques Francaises
|
July 12, 2025
Oncology pharmacy practice: Key insights, challenges, and perspectives - A position paper from the French Society for Oncology Pharmacy (SFPO)
Florence Ranchon, Florian Slimano, Isabelle Borget, et al.
Annals of Hematology
|
October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
Emilie Fargier, Florence Ranchon, Laure Huot, et al.
Hematological Oncology
|
October 23, 2025
The French Experience of Pharmacists and CAR T-Cells: A Study of the French Society of Oncology Pharmacy (SFPO)
Vérane Schwiertz, Romain de Jorna, Adeline Quintard, et al.
Cancers
|
February 15, 2022
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
Bastien Collomb, Amélie Dubromel, Anne Gaëlle Caffin, et al.
Page
of 6